Related references
Note: Only part of the references are listed.Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis
Takashi Matozaki et al.
CANCER SCIENCE (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway
Li Rong et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Propofol Inhibits the Migration and Invasion of Glioma Cells by Blocking the PI3K/AKT Pathway Through miR-206/ROCK1 Axis
Dongmei Wang et al.
ONCOTARGETS AND THERAPY (2020)
Nuclear Functions of the Tyrosine Kinase Src
Giulia Bagnato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Turn and Face the Strange: A New View on Phosphatases
Maja Koehn
ACS CENTRAL SCIENCE (2020)
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
Michelle C. Turner et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma
Hao Zhang et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
Siran Xu et al.
CELL DEATH & DISEASE (2019)
Morphine inhibits cell viability and growth via suppression ofvascular endothelial growth factor in human oral cancer HSC-3 cells
Tadashi Nishiwada et al.
JOURNAL OF ANESTHESIA (2019)
Morphine contributed to the deterioration of cancer via miR-543/MARCKS/FcγR-mediated phagocytosis pathway
Jianghui Luo et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
Francisco Hermida-Prado et al.
CANCERS (2019)
Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
Fabio Barra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Deguelin induces PUMA-mediated apoptosis and promotes sensitivity of lung cancer cells (LCCs) to doxorubicin (Dox)
Aimei Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-κB Signaling Pathways
Yung-Ting Hsiao et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2018)
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma
Anne S. Tsao et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway
Chang Seong Kim et al.
BIOLOGY OF THE CELL (2018)
Influence of opioids on immune function in patients with cancer pain: from bench to bedside
Jason W. Boland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Antitumor Effects of Deguelin on H460 Human Lung Cancer Cells In Vitro and In Vivo: Roles of Apoptotic Cell Death and H460 Tumor Xenografts Model
Yu-Chieh Hsu et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway
Shimaa M. Hassoun et al.
TUMOR BIOLOGY (2017)
Morphine Can Inhibit the Growth of Breast Cancer MCF-7 Cells by Arresting the Cell Cycle and Inducing Apoptosis
Yanhua Chen et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC
Zi Wang et al.
ONCOTARGET (2016)
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Elena Bandieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
K. Balakrishnan et al.
LEUKEMIA (2015)
Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma
Y. -F. Zhang et al.
DISEASES OF THE ESOPHAGUS (2015)
Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis
D. P. Maher et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
Increased μ-opioid receptor expression in metastatic lung cancer
P. A. Singleton et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer
J. Nguyen et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer
Frances E. Lennon et al.
PLOS ONE (2014)
Opioid Requirement, Opioid Receptor Expression, and Clinical Outcomes in Patients With Advanced Prostate Cancer
Dylan Zylla et al.
CANCER (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
The role of morphine in regulation of cancer cell growth
Katarzyna Gach et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Morphine Suppresses Tumor Angiogenesis through a HIF-1α/p38MAPK Pathway
Lisa Koodie et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways
Po-Ni Hsiao et al.
TOXICOLOGY (2009)
Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells
Chunsheng Chen et al.
CURRENT NEUROVASCULAR RESEARCH (2006)
Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells
KH Chun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases
L Tatton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells
Y Harimaya et al.
CANCER LETTERS (2002)
Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain:: Impact on pain, drug-related toxicity, and survival
TJ Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine
P Klepstad et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
